{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:06:34Z","timestamp":1787015194791,"version":"build-2736575974"},"reference-count":33,"publisher":"Tech Science Press","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1299,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1747-0803.2011.00620.x","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T12:13:12Z","timestamp":1328875992000},"page":"259-267","source":"Crossref","is-referenced-by-count":48,"title":["B-type Natriuretic Peptide and Amino-terminal Pro-B-type Natriuretic Peptide in Pediatric Patients with Pulmonary Arterial Hypertension"],"prefix":"10.32604","volume":"7","author":[{"given":"Shinichi","family":"Takatsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Dunbar","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2012,2,10]]},"reference":[{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cccn.2004.06.018","article-title":"Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?","volume":"349","author":"Pfister","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-5299.2004.03271.x","article-title":"BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases","volume":"10","author":"Silver","year":"2004","journal-title":"Congest Heart Fail"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.clinbiochem.2004.06.009","article-title":"Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea","volume":"37","author":"Alibay","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI118162","article-title":"Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an \u201cemergency\u201d cardiac hormone against ventricular overload","volume":"96","author":"Nakagawa","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin Chem"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0195-668X(03)00476-7","article-title":"Clinical applications of B-type natriuretic peptide (BNP) testing","volume":"24","author":"Cowie","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2459\/JCM.0b013e32832401d6","article-title":"The use of B-type natriuretic peptide in paediatric patients: a review of literature","volume":"10","author":"Favilli","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.0000143059.68996.A7","article-title":"Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial","volume":"110","author":"Hartmann","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/CCLM.2001.093","article-title":"The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure","volume":"39","author":"Mair","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1253\/circj.71.1873","article-title":"Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure","volume":"71","author":"Tsutamoto","year":"2007","journal-title":"Circ J"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1378\/chest.128.4.2368","article-title":"Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension","volume":"128","author":"Leuchte","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1378\/chest.08-0187","article-title":"Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension","volume":"135","author":"Bernus","year":"2009","journal-title":"Chest"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2008.03.009","article-title":"Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension","volume":"135","author":"Lammers","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1203\/PDR.0b013e318163a2e7","article-title":"Biological serum markers in the management of pediatric pulmonary arterial hypertension","volume":"63","author":"Van Albada","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies","volume":"106","author":"van Loon","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-2607(02)00017-2","article-title":"Bivariate linear mixed models using SAS proc MIXED","volume":"69","author":"Thiebaut","year":"2002","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","article-title":"Essential biochemistry and physiology of (NT-pro)BNP","volume":"6","author":"Hall","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cccn.2003.08.016","article-title":"Multicenter evaluation of the roche NT-proBNP assay and comparison to the biosite triage BNP assay","volume":"338","author":"Yeo","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","article-title":"N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension","volume":"131","author":"Leuchte","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cca.2005.11.005","article-title":"Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals","volume":"366","author":"Soldin","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1542\/peds.112.4.896","article-title":"Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth","volume":"112","author":"Mir","year":"2003","journal-title":"Pediatrics"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1651-2227.2004.tb02984.x","article-title":"N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases","volume":"93","author":"Nir","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/heart.89.8.875","article-title":"Normal values of B type natriuretic peptide in infants, children, and adolescents","volume":"89","author":"Koch","year":"2003","journal-title":"Heart"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1388-9842(03)00108-9","article-title":"Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate","volume":"5","author":"Loke","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2004.01.013","article-title":"Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study","volume":"147","author":"Maisel","year":"2004","journal-title":"Am Heart J"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)02464-5","article-title":"Impact of age and sex on plasma natriuretic peptide levels in healthy adults","volume":"90","author":"Wang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1747-0803.2011.00620.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/08035250500466647","article-title":"Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age","volume":"95","author":"Koch","year":"2006","journal-title":"Acta Paediatr"}],"container-title":["Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0803.2011.00620.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T18:01:08Z","timestamp":1588010468000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1747-0803.2011.00620.x"}},"subtitle":["Comparison of Brain Natriuretic Peptides"],"short-title":[],"issued":{"date-parts":[[2012,2,10]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1747-0803.2011.00620.x","relation":{},"ISSN":["1747-079X"],"issn-type":[{"value":"1747-079X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,10]]}}}